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P.  jirovecii independent of environ-
mental hazards.
Isolation of pathogens from an 
aborted fetus does not necessarily 
mean that they have caused the death 
of the fetus because many agents ap-
pear to pass through the fetal-placental 
unit and cause little damage. Howev-
er, fungal infection is a major world-
wide cause of abortion in cattle (10), 
and the surprising high prevalence of 
P. jirovecii infection found in dead fe-
tuses in our study emphasizes the need 
to study the possible role of this fungal 
organism in human abortion.
Our ﬁ  ndings could be of potential 
clinical importance and could open a 
new  ﬁ  eld of research, which should 
be explored. Further research should 
assess the scope of the problem and 
design rational preventive strategies, 
if necessary.
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Avian Inﬂ  uenza 
Virus (H5N1) in 
Human, Laos 
To the Editor: The ﬁ  rst avian in-
ﬂ  uenza (H5N1) outbreak in poultry in 
Laos occurred in 2003 and subsided 
in March 2004 after massive killing 
of poultry to contain the disease. Ex-
tensive surveillance from July 2005 
through January 2006 did not detect 
any inﬂ  uenza virus subtypes in chick-
en, ducks, quails, and pigs in live bird 
markets in the Vientiane, Champa-
sak, and Savannakhet Provinces (1). 
Avian inﬂ   uenza virus (H5N1) was 
reintroduced into Laos in February 
2006 but showed a lower incidence. 
Viruses isolated in this country in 
2004 belonged to genotype Z, clade 
1, and 2006 isolates belonged to clade 
2.3.4 (online Appendix Figure, panel 
A, available from www.cdc.gov/EID/
content/15/1/127-appF.htm) (1).
Avian inﬂ  uenza (H5N1) had not 
been reported in humans in Laos un-
til February 27, 2007 (2). Our patient 
was a 15-year-old adolescent girl who 
lived in a suburb of Vientiane where 
an outbreak of inﬂ   uenza (H5N1) in 
poultry had been conﬁ  rmed on Febru-
ary 7, 2007. Inﬂ  uenza-like symptoms 
developed in the patient on February 
10. She was hospitalized in Vientiane 
with fever and respiratory symptoms 
on February 15. On February 17, her 
parents brought her to a private hospi-
tal in Nong Khai Province, Thailand. 
Oseltamivir was prescribed on Febru-
ary 19. On February 20, she was trans-
ferred to the Nong Khai Provincial 
Hospital because of rapid, progressive, 
severe pneumonia with acute respira-
tory distress syndrome. When we sus-
pected avian inﬂ  uenza in this patient, 
clinical specimens were tested.
A diagnosis of infection with 
avian inﬂ  uenza (H5N1) was based on 
positive results obtained by reverse 
transcription–PCR (RT-PCR), viral 
isolation in MDCK cells inoculated 
with an endotracheal suction specimen 
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collected on February 22, and a 4-fold 
increase in neutralizing antibody titers 
from 80 to 320 in paired blood speci-
mens collected on February 25 and 
March 1, as assayed against autologous 
virus. This virus isolate was named A/
Laos/Nong Khai 1/07(H5N1). Subse-
quent samples were collected on Feb-
ruary 25 and March 7 (day of death). 
Results of RT-PCR were positive for 
the sample collected on February 25 
only; virus isolation results were nega-
tive for both samples.
The virus was screened for a nov-
el reassorted gene by a multiplex RT-
PCR and 8 primer pairs speciﬁ  c for 
each genomic segment of genotype Z, 
clade 1 virus (3). All segments except 
the polymerase A (PA) segment were 
ampliﬁ   ed, which indicated that the 
new virus was different from geno-
type Z viruses. The viral genome was 
sequenced and submitted to GenBank 
(accession nos. EU499372–EU499379 
for hemagglutinin, nonstructural pro-
tein, matrix protein, nucleoprotein, 
PB1, PB2, neuraminidase, and PA 
genes, respectively). Phylogenetic 
analysis showed that this virus be-
longed to genotype V (online Appen-
dix Figure, panel B) (4); phylogenetic 
analysis of the hemagglutinin gene 
(www.who.int/csr/disease/avian_
inﬂ   uenza/smaltree.pdf) showed that 
it belonged to clade 2.3.4 (online Ap-
pendix Figure, panel A).
Protein sequence at the hemag-
glutinin cleavage site harbored many 
basic amino acids (RERR_RKR). One 
amino acid deletion and 1 amino acid 
change were found when compared 
with RERRRKKR, which is present in 
most avian inﬂ  uenza viruses (H5N1). 
There was no change in receptor bind-
ing site. This virus had glutamic acid 
at aa 627 in the PB2 protein, aspartic 
acid at aa position 92 in nonstructural 
protein 1, and 5 aa deletions at posi-
tions 80–84 in the nonstructural pro-
tein 1. Analysis of the neuraminidase 
gene showed a 20-aa deletion in the 
stalk protein; there was no mutation of 
histidine to tyrosine at aa position 274, 
a position shown to be the oseltamivir 
resistance marker in the neuraminidase 
1 viral genome (5). Mutations in the 
matrix 2 gene showed that amantadine 
resistance was not present in our virus 
(6). Our in vitro assay (7) showed that 
this virus was sensitive to oseltamivir 
and amantadine.
Since 2003, genotype V inﬂ  uenza 
viruses (H5N1) have been reported in 
some East Asian countries. Genetic di-
versity in the hemagglutinin gene has 
classiﬁ   ed those genotype V viruses 
into distinct clades. Viruses from avian 
species in South Korea in 2003 and Ja-
pan in 2004 (8,9) belong to clade 2.5. 
A/chicken/Shanxi/2/2006 isolate be-
longed to clade 7. Human cases in Peo-
ple’s Republic of China, i.e., A/China/
GD01/06, A/Shenzhen/406H/06, A/
Jiangsu/1/2007, and A/Jiangsu/2/2007, 
belong to clade 2.3.4, the same clade 
as A/chicken/Thailand/NP-172/2006 
and the virus from our study.
Highly pathogenic avian inﬂ  u-
enza viruses (H5N1) that caused out-
breaks in Thailand since 2004 belong 
to genotype Z, clade 1. Introduction of 
genotype V clade 2.3.4 virus, A/chick-
en/Thailand/NP-172/2006, to Nakhon 
Phanom Province occurred in No-
vember 2006 (10), the same year that 
clade 2.3.4 virus was introduced into 
Laos (online Appendix Figure, panel 
A). On the basis of hemagglutinin 
gene phylogeny, A/Laos/Nong Khai 
1/2007 is closely related to A/chicken/
Nongkhai/NIAH 400802/2007 and 
A/chicken/Thailand/NP-172/2006. 
Phylogenetic analysis suggested that 
viruses from these 2 countries shared 
the same origin. There was extensive 
movement across the Mekong River 
even before the bridge linking Nong 
Khai from Vientiane was opened. 
However, the route of transmission of 
genotype V viruses from east Asian to 
Southeast Asian countries could not 
be elucidated.
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Fatal HIV
Encephalitis in 
HIV-Seronegative 
Patients
To the Editor: Acute encephalitis 
is rarely seen in patients infected with 
HIV (1). In addition, HIV in patients 
who are seronegative is extremely 
rare, particularly in the setting of cur-
rent screening ELISAs (2). We report 
a case of encephalitis and HIV in the 
same patient, which resulted in death.
A 44-year-old Caucasian woman 
sought treatment at our hospital with a 
1-week history of fever, unsteady gait, 
and progressive confusion. Her medi-
cal history included hypothyroidism, 
depression, and chronic alcohol abuse. 
The patient’s ﬁ  rst tests for HIV were 
negative at 19 and 12 months prior 
to admission during routine intake 
screening for jail inmates (Abbott HIV 
AB HIV-1/HIV-2 [rDNA] enzyme im-
munoassay [EIA] kit; Abbott Labo-
ratories, Abbott Park, IL, USA). Six 
months before admission, the patient 
had a viral exanthem of blistering rash 
on her lips, palate, and chest.  Two 
weeks later, she had oral thrush and 
a leukocyte count of 1,700 cells/μL. 
An HIV ELISA result was negative. 
Three months before admission, she 
was admitted to a different hospital 
for weakness, abdominal pain, inter-
mittent fever, diarrhea, persistent oral 
candidiasis, and ethanol withdrawal. 
She had leukopenia and thrombocy-
topenia. A fourth HIV ELISA result 
was negative. The patient had been ad-
mitted to our hospital one week before 
the current admission with symptoms 
of fever, confusion, and urinary tract 
infection. Lumbar puncture showed an 
elevated protein level (106 mg/dL). A 
ﬁ  fth HIV test result 6 days before most 
recent admission was negative. Five 
days before admission, she had been 
discharged to a rehabilitation facility.
On this hospitalization, she had 
fatigue, headache, disequilibrium, 
dysarthria, and blurred vision.  Initial 
examination showed fever of 101.3°F, 
poor word recall, and a wide-based 
gait. Laboratory tests showed mild 
anemia and a leukocyte count of 2 × 
103 cells/μL.
Over the next few days the pa-
tient’s fever persisted and her mental 
status  ﬂ   uctuated.  Tests on hospital 
day 2 showed a CD4 count of 101/mL 
(16.9%). Magnetic resonance imag-
ing (MRI) of the brain showed diffuse 
symmetric white matter disease (Fig-
ure, panel A).  Samples sent on hos-
pital day 9 eventually showed wild-
type HIV with a viral load >500,000 
copies/mL. Repeat cerebrospinal ﬂ  uid 
(CSF) test results were negative for 
cryptoccocus antigen, and PCR results 
were negative for cytomegalovirus, 
herpes simplex virus (HSV), and JC 
polyoma virus. The next day, a sixth 
HIV ELISA result was negative. The 
serum level of HIV p24 antigen was 
202 pg/mL.
On hospital day 13, the patient 
began treatment with zidovidine, la-
muvidine, didanosine, and nevirap-
ine. Within 24 hours, seizures and 
catatonia developed in the patient. An 
electroencephalogram showed diffuse 
wave form slowing. A repeat MRI 
showed worsened white matter dis-
ease (Figure, panel B). The result of 
a seventh HIV screening ELISA per-
formed on hospital day 15 was nega-
tive. Two days later, the HIV viral load 
was 241,789 copies/mL. On hospital 
day 19, her serum levels were within 
normal limits: immunoglobulin (Ig) 
M level (164 mg/dL), IgG level (1,440 
mg/dL), a 3× normal IgA level (1,060 
mg/dL), and no oligoproteins. The 
CSF had an IgG level >10× normal 
(72 mg/dL), elevated IgG levels for 
HSV1 (1:160) and HSV2 (1:40), was 
negative for virus culture, and showed 
a negative PCR result for JC polyoma 
virus. On hospital day 23, the eighth 
HIV ELISA result was negative. The 
Abbott HIVAB HIV-1/HIV-2 (rDNA) 
EIA was used throughout the hospital-
ization. On hospital day 24, supportive 
care was withdrawn and the patient 
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